Corporate Partners
Penn bioengineers are not only changing our knowledge of basic science, but they are bringing new tools and discoveries into practice to improve patient care. Below is a list of BE faculty who are partnering with industry to bring new technology and treatments from the laboratory to the patient. New ventures are being explored by BE faculty on a continuing basis.
| Faculty Member | Company | Research/Technology |
| Jason Burdick | Penn Spin-off Company (Unnamed) |
New treatments for congestive heart failure |
Coulter commercialization grant for vascular graft material held jointly with Drexel |
Longer lasting grafts for coronary artery bypass and lower limb ischemia |
|
Reaction Biology |
Tools for nanoscale high throughput drug screening |
|
OrthoVita and Gentis |
Orthopedic implants and tissue engineering |
|
Critical Biologics |
New biologic for treating toxic shock |
|
NeuroPace; MC10 |
Implantable tools and computer algorithms for predicting epileptic seizures and sudden cardiac death |
Corporations seeking partnerships with our faculty researchers should visit the Penn Engineering website.